financetom
Business
financetom
/
Business
/
Nature's Miracle Starts EV Business in US, South America; Shares Surge
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nature's Miracle Starts EV Business in US, South America; Shares Surge
Nov 9, 2024 12:31 PM

02:29 PM EST, 11/07/2024 (MT Newswires) -- Nature's Miracle (NMHI) said Thursday its subsidiary will launch a new business with focus on marketing and distribution of electric-powered agriculture vehicles and commercial vehicles in the US and South America.

The company said its unit, Hydroman, will become Hydroman Electric Corporation to align with its new business plan.

Last month, the agriculture technology firm said it will order 150 electric trucks from Robostreet to diversify its business.

Nature's Miracle shares were up about 60% in recent trading.

Price: 0.15, Change: +0.06, Percent Change: +59.75

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Brazilian airline Azul lowers 2024 earnings and capacity forecasts
Brazilian airline Azul lowers 2024 earnings and capacity forecasts
Aug 12, 2024
SAO PAULO, Aug 12 (Reuters) - Brazilian airline Azul ( AZUL ) reduced its estimate for 2024 core earnings on Monday while bumping up its leverage forecast in the face of slower than previously expected capacity growth and weakness of Brazil's currency. Azul ( AZUL ) now expects earnings before interest, tax, depreciation and amortization (EBITDA) to be more than...
Revance Therapeutics to Be Acquired by Crown Laboratories for $924 Million
Revance Therapeutics to Be Acquired by Crown Laboratories for $924 Million
Aug 12, 2024
08:35 AM EDT, 08/12/2024 (MT Newswires) -- Revance Therapeutics ( RVNC ) has agreed to be acquired by Crown Laboratories for $924 million, the companies said Monday. Under their merger agreement, Crown will make a tender offer to acquire all outstanding Revance shares for $6.66 each, an 89% premium to Friday's close, according to the companies. They said Revance's board...
Masimo Says US FDA Clears Masimo W1 Medical Watch Connectivity With SafetyNet Telemonitoring System
Masimo Says US FDA Clears Masimo W1 Medical Watch Connectivity With SafetyNet Telemonitoring System
Aug 12, 2024
08:35 AM EDT, 08/12/2024 (MT Newswires) -- Masimo ( MASI ) said Monday its Masimo W1 medical watch has received the US Food and Drug Administration's clearance to integrate it with the Masimo SafetyNet comprehensive telemonitoring solution. The integration provides improved patient data through the wrist, which will be available on the Masimo SafetyNet smartphone app and its web-based clinician...
Ascendis Pharma's hormone disorder therapy gets US approval
Ascendis Pharma's hormone disorder therapy gets US approval
Aug 12, 2024
By Sneha S K and Sriparna Roy Aug 12 (Reuters) - Ascendis Pharma ( ASND ) said on Monday the U.S. Food & Drug Administration had approved its therapy to treat adult patients with a hormone disorder, sending the Danish drugmaker's shares more than 10% higher in premarket trading. Ascendis's Yorvipath, will become the only approved treatment for the condition,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved